PTPN11 and Noonan syndrome: Activating mutations of Shp2, which drive oncogenic Ras signaling, are associated with human cancers and Noonan syndrome (NS) (Tartaglia et al, 2001; Xu et al, 2010; Zhang et al, 2015).